What is KLRS's price / book?

KLRS (KLRS) reported price / book of 1.9× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

KLRS KLRS Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

Merck & Co.MRK

6.5×+1.8×

AmgenAMGN

20.6×-6.3×

Regeneron PharmaceuticalsREGN

2.6×+0.2×

EyePoint, Inc. EYPT

4.7×+3.4×

Ocular TherapeutixOCUL

3.2×-1.2×

Other financials

Income statement

See full

Operating income-$11.8M-14.3%

Net income-$10.9M-6.5%

EPS (diluted)-$0.46+81.7%

Balance sheet

See full

Cash & equivalents$34.4M-65.9%

Total debt$1.4M—

Total equity$68.6M+7.3%

Total assets$109.8M+6.5%

Cash flow

See full

Operating cash flow-$11.6M-55.6%

CapEx$17.0K—

Free cash flow-$7.1M—

Valuation

See full

Market cap$96.83M+136%

Enterprise value$63.82M—

Returns & leverage

See full

Return on equity-66.6%—

Debt / equity0×—

Current ratio12.2×-2.1×

Where this comes from

Calculated from KLRS’s reported figures.

market cap/total stockholders equity=1.9×

Based on the most recent quarter.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KLRS's price / book?: KLRS (KLRS) reported price / book of 1.9× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.